Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a ... related to the specific lesions in the pathology of NASH, including the challenges of pediatric ...

The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

Study highlights the role of the Nwd1 gene in liver disease, paving the way for new therapies and better liver health Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease ...

The findings from the new study in The American Journal of Pathology ... progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver ...

PathAI, a global leader in AI-powered pathology, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted full qualification for ...

The findings from the new study in The American Journal of Pathology ... progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses ... A key factor in the pathology ...

“A robust, automated and highly standardized method to assess liver histological ... of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis.